Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case.

Publication Year: 2024

DOI:
10.1136/jitc-2023-007612

PMCID:
PMC10773440

PMID:
38177075

Journal Information

Full Title: J Immunother Cancer

Abbreviation: J Immunother Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability statement the gene expression dataset of tumor samples is deposited in gene expression omnibus with accession number gse171484. these results indicate that tumor genetic evolution was shaped by treatment with the brafi which led to the selection of melanoma subpopulations carrying mutations related to acquired brafi resistance 10 1136/jitc-2023-007612 supp2 supplementary data 10 1136/jitc-2023-007612 supp1 supplementary data figure 2 genetic and transcriptional profiles of t1-t4 tumor samples (a) pathogenic gene variants detected by targeted mutation analysis performed by the ion torrent personal genome platform (thermofisher scientific) (b) copy number alteration (cna) genomic plots obtained by analysis by oncoscan cnv arrays (affymetrix). data availability statement the gene expression dataset of tumor samples is deposited in gene expression omnibus with accession number gse171484"

Code Sharing
Evidence found in paper:

"Competing interests: None declared."

Evidence found in paper:

"Funding: Ministero della Salute: RCR2020 to ACC Melanoma Working Group, and Ricerca Corrente; AIRC IG17462; CARIPLO Foundation (2015-0911, VV support)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025